Interestingly, clustering analysis based on the MAP genes showed that NB tumors were grouped by MYCN status, progression events, high risk, or death from NB (Figure 2A), indicating that MAP gene expression were associated with amplified MYCN, tumor progression, higher clinical risk and higher risk of death of NB tumors. Here, MYCN is linked to neuroblastoma.